Karin Sartorius-Herbst is a German businesswoman, the billionaire Chairman of the Supervisory Board of Sartorius AG (ETR: SRT), a major global supplier of laboratory and bioprocess technology. Her wealth is generational, tied to the industrial empire founded by her great-grandfather, Florenz Sartorius, in 1870 (who started by manufacturing short-beam analytical balances).

Sartorius-Herbst's career is defined by generational stewardship and fiduciary oversight of the complex, high-tech scientific firm. She and her cousins, Ute Maria Vais and Martina Kamp-Hausen, control the majority of the family's voting shares. Her structural role is tied to ensuring the company maintains its commitment to scientific innovation and long-term growth in the essential biotechnology and life sciences sector.

• Sartorius AG (Chairman of the Supervisory Board): The core publicly traded asset, a global leader in laboratory and bioprocess technology (supplying the pharmaceutical and biotech industries).
• Family Governance: She and her cousins control the majority of the voting rights through the complex family holding structure.
• Technological Focus: Her fortune is tied to the successful industrialization of scientific equipment (balances, filtration, cell culture media).
• Philanthropy: She supports the Sartorius Cultural Fund and other philanthropic initiatives focused on science and education.

Karin Sartorius-Herbst's strategic leadership involves managing the long-term governance and financial direction of Sartorius AG. The company's success is rooted in its commitment to continuous R&D and its focus on high-value bioprocess technology (which includes filtration, fermentation, and cell culture media—essential for drug manufacturing).

Her structural contribution is tied to the successful generational transition and modernization of a family-owned industrial asset into a global public company (employing over 15,000 people). She and her cousins maintain control over the majority of the voting shares, ensuring the family's long-term strategic vision is executed. Her wealth is secured by the colossal, long-term, stable profitability of the global biotechnology and life sciences equipment sector.

Karin Sartorius-Herbst's social impact is structural, stemming from Sartorius AG's role in providing essential equipment and consumables for global drug development, manufacturing, and medical research. The company's technology is critical to the efficiency of the entire biopharmaceutical supply chain. Her personal philanthropy supports various community and cultural initiatives.

Her structural contribution is tied to the successful generational stewardship and technological leadership of a critical industrial asset.

Karin Sartorius-Herbst maintains the professional, composed style of an industrial executive. Her attire is consistently formal and high-quality, favoring tailored business suits. Her aesthetic reflects stability and serious authority, typical of a leader in the specialized medical technology sector.

Residing in Göttingen, Germany, her luxury is the immense security and financial reward derived from her multi-billion euro fortune. Her life is dedicated to industrial scale, technological innovation, and the long-term, stable growth of the global life sciences equipment sector.